
One year after Roux-en-Y gastric bypass (RYGB) surgery, persistent intestinal adaptation was observed in all patients, regardless of type 2 diabetes remission or weight loss. Analysis of gene expression (GE) from paired jejunal (Roux limb) samples of 28 patients indicated sustained remodeling, marked by a 39% elongation of microvilli. This remodeling was not diminished in those experiencing weight regain or lack of diabetes remission. Patients achieving diabetes remission displayed enhanced activation of lipogenesis pathways in the jejunum, particularly driven by RXR, LXR, and SREBP signaling. These findings suggest that while RYGB induces widespread intestinal adaptation, enhanced jejunal lipogenesis may contribute to the mechanisms underlying metabolic improvement and diabetes remission.
Like
Save
Share